SEF Chemo

Note: Only available in USA

Berkeley Institute International are treating patients with SEF Chemo – a new treatment that is reportedly side-effects free. Here is some info from its website:
SEF Chemo® is designed not only to minimize toxicity, but also to make chemotherapy more effective. Usually, only a fraction of the cells in a tumor is directly and immediately destroyed during chemotherapy.  Many more cells are merely damaged.  These damaged cells can repair themselves, continue to multiply, and spread the cancer.

There is a well-known process within the body’s immune system, called the Neutrophil Cascade, in which one type of neutrophil cells circulate in the body searching for and marking sick and damaged cells.  Other neutrophil cells dissolve these damaged cells.  It is a mechanism organisms have evolved to rid the body of sick and aging cells.  Conventional chemotherapy, however, destroys neutrophil cells in the marrow so that the only cancer cells that get killed during conventional chemotherapy are those directly and lethally hit.  Cancer cells that are merely damaged survive, leaving the body vulnerable to the spread of cancer.

SEF Chemo® solves this problem by protecting neutrophil cells, thereby ensuring they can identify and dissolve damaged cancer cells, and in that way, the patient’s immune system can naturally amplify the effectiveness of the therapy.

Where conventional chemotherapy may destroy only 60% of cancer cells in the body, SEF Chemo®, using a side effect-reducing medicament, may destroy 95% of cancer cells.  For this reason, we find tumors shrinking over weeks with SEF Chemo® compared to months with conventional chemotherapy.


In April 2010, Dr. Matsumura and his colleagues at the ALIN Foundation announced an historic achievement: all cancer patients treated with the SEF Chemo® in 2006 not only went into remission, but remained cancer-free without the toxic side effects normally associated with chemotherapy.

The results on patients undergoing SEF Chemo® are nothing short of stunning.  One oncologist, who regularly refers patients to us, remarked that he knows of no other place in the world where achievements such as ours are being accomplished.

Results are still early, but we are getting response on virtually every patient we treat, as compared to the 20-30% response rates of conventional chemotherapy on the types of cancers we are treating.  If we begin treatment while the volume of cancer cells in a patient is still limited (as opposed to advanced late stage IV), we are achieving clinical remissions consistently.  By clinical remission we mean that when we use imaging studies with x-rays, MRIs, or ultrasound we cannot find any trace of cancer. Continue learning more at Berkeley Institute International

Patient Testimonials

Academy Award winner William Hurt on SEF Chemo

YouTube player
YouTube player
YouTube player
YouTube player


Updated 2024

Please share this page to help others